← Back to headlines
Novo Nordisk Lowers Prices for Ozempic and Wegovy in Spain
Novo Nordisk has announced price reductions of up to 17.6% for its diabetes and obesity drugs, Ozempic and Wegovy, in Spain, with Wegovy's highest dose dropping to 223.64 euros.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
